Fact Check: Does Boops Pets’ ’30 Billion CFU’ Actually Survive to Expiration?

Fact Checks · 15 min read

✓ Our Fact-Checking Team — July 30, 2026

Table of Contents

• The Claim Under Review
• Why “At Expiration” Is the Only Phrase That Matters
• The Industry-Wide Label Accuracy Problem
• The Soft-Chew Format Makes Stability Harder
• What Would Need to Be True vs. What Is Published
• How a Postbiotic Approach Changes the Question Entirely
• What to Ask Any Supplement Company
• Our Verdict and Why
• Frequently Asked Questions
• References

The Claim Under Review

Boops Pets markets a probiotic soft chew positioned around a headline number: 30 Billion CFU, spread across a multi-strain blend and paired with digestive enzymes. The brand leans heavily on quality signals — a NASC Quality Seal, references to third-party testing, and a premium “filet mignon” positioning. On marketplaces the product carries strong review volume and high star ratings.

None of that’s what we’re checking here. Reviews and seals speak to customer satisfaction and manufacturing hygiene; they don’t, by themselves, confirm that the number printed on the pouch is the number of viable organisms your dog actually ingests on the last day of shelf life. The specific claim under review is narrow and technical: does the labeled 30 Billion CFU survive to expiration?

This is a fair question to ask of any live-culture product, and we’ve asked it before. Our broader analysis of the “more CFU = better” claim established that raw CFU numbers are a weak proxy for efficacy even when they’re accurate. This article goes one step further and asks whether a specific brand’s number can be trusted at all.

Why “At Expiration” Is the Only Phrase That Matters

Colony-forming units (CFU) measure the number of microorganisms capable of reproducing under laboratory conditions. The critical detail that most marketing omits is when a given count is true. A count can be measured at three very different moments:

• At manufacture. The day the product is made. This is the highest the count will ever be.
• At some midpoint. An internal quality-control checkpoint that may never be disclosed.
• At expiration. The last day the product is sold as usable. This is the lowest the count will be — and the one that actually corresponds to what a customer feeds their dog near the end of the pouch’s life.

A “guaranteed at expiration” claim is the most consumer-friendly version of the claim, because it promises the labeled count at the worst-case moment. It’s also the most difficult to substantiate, because it requires the manufacturer to demonstrate — usually through accelerated and real-time stability studies — that viability remains above the labeled threshold after months of storage, shipping, and temperature fluctuation.

Live probiotics are, by definition, alive. Everything alive dies. Between the factory and your dog’s bowl, viability erodes through heat exposure during shipping and storage, moisture ingress, oxygen exposure, and ordinary time-dependent die-off even under ideal conditions. The International Scientific Association of Probiotics and Prebiotics (ISAPP) notes that manufacturers of live probiotics commonly have to overfill^[5] their products by 1.5 to 4 times the labeled count just to compensate for expected die-off during shelf life. That overfilling is an admission that the labeled number and the manufactured number aren’t the same thing.

So the question isn’t whether Boops Pets put 30 billion organisms into the chew at the factory. The question is whether 30 billion remain viable on the last day of shelf life — and whether anyone independent has confirmed it.

The Industry-Wide Label Accuracy Problem

We aren’t singling out Boops Pets because we’ve evidence that their product fails. We’re applying appropriate skepticism because the veterinary probiotic category as a whole has a documented, repeatable accuracy problem. When independent researchers have actually plated out commercial products and counted what is alive, the results have been consistently poor.

The landmark study: 27% accuracy

In 2011, Weese and Martin analyzed commercial veterinary probiotic products and compared the viable contents to the label claims. The headline finding: only 2 of 15 products (27%) with specific CFU claims met or exceeded their labeled count. Viable growth across the products ranged from zero to 2 × 10⁹ CFU/g, and some labels listed organisms that the researchers couldn’t recover at all. The authors concluded that “most commercial veterinary probiotic preparations are not accurately represented by label claims” and that “quality control appears to be poor for commercial veterinary probiotics” (Weese & Martin, 2011; PMC3003573).

This wasn’t an obscure finding. It has been replicated and echoed for two decades. An earlier evaluation found that only 2 of 13 products had labels that accurately described their actual contents; five products were missing one or more stated organisms, and some contained organisms with no reported probiotic effect (Weese, 2002; PMID: 11918274).

The problem persists into the current decade

A 2020 assessment of commercial companion-animal kefir^[2] products found that every product with a guaranteed CFU/g overstated the number of microorganisms present by at least one log (a factor of ten), and that none of the labels claiming specific bacterial genera and species were correct (Metras et al., 2020; DOI: 10.1093/jas/skaa301).

A 2017 review in the Journal of the American Veterinary Medical Association summarized the scope bluntly: products containing live organisms “leads to actual microorganism concentrations that range from 0.008% to 215% of the labeled concentrations,” and all eight veterinary products evaluated in one study “contained concentrations for individual microorganisms that were <2% of label claims” (Jugan et al., 2017; PMID: 28207322). Read that range again: from roughly one-hundredth of one percent to more than double the label. That isn’t a tight, well-controlled category.

The implication for our fact-check is straightforward. When the base rate of label accuracy across the entire category is this poor, a single brand’s unverified claim deserves scrutiny rather than trust. The burden of proof sits with the manufacturer.

The Soft-Chew Format Makes Stability Harder

Format matters. The same organism will survive very differently in a freeze-dried powder, an encapsulated bead, and a moist soft chew. Boops Pets’ probiotic is a soft chew, and soft chews are among the most challenging formats for live-culture stability.

• Water activity. Soft chews are palatable precisely because they’re moist. But moisture is the enemy of bacterial shelf life. Higher water activity accelerates metabolic stress and die-off in dried organisms.
• Heat during production. The extrusion and baking steps used to form chews can expose organisms to temperatures that reduce viability before the product even ships.
• Oxygen and packaging. A pouch that’s opened and re-closed repeatedly over a month of feeding introduces oxygen and humidity cycling that further erodes counts.

This isn’t a theoretical concern limited to one brand. It’s one reason our scoring rubric on sister sites treats the soft-chew format as a stability risk for any live-culture product, and it’s why the most clinically studied veterinary probiotic on the market is delivered as a powder sachet rather than a chew. A chew can be an excellent delivery format for stable, non-living ingredients; it’s a genuinely difficult format for guaranteeing a live count at expiration.

It’s worth separating two things that consumers routinely conflate. A NASC Quality Seal and third-party testing for contaminants (heavy metals, microbes, pesticides) are meaningful hygiene and transparency signals. They aren’t the same thing as a third-party potency-at-expiration verification. A product can pass a contaminant panel and still fall far short of its labeled CFU on the last day of shelf life. These are different tests, answering different questions.

What Would Need to Be True vs. What Is Published

To responsibly call a “30 Billion CFU guaranteed at expiration” claim verified, a fact-checker would want to see a specific set of evidence. The table below lays out what that evidence would look like, and what we were able to locate in the public domain for this specific product.

The pattern is important. The evidence that is publicly available speaks to manufacturing quality and contaminant testing. The evidence that would specifically substantiate a “guaranteed at expiration” potency claim — stability data, an expiration COA, a third-party potency assay — isn’t in the public domain. That’s the definition of an unverifiable claim: not false, but unsupported by anything we can inspect.

For contrast, see our independent review of whether pet supplement brands actually test their products, which walks through the difference between testing for safety and testing for verified potency.

How a Postbiotic Approach Changes the Question Entirely

There’s a structural reason this whole line of questioning exists, and it’s worth naming plainly: the CFU-survival problem only exists because the active ingredient is alive. Change the category, and the question dissolves.

In 2021, the ISAPP published a consensus statement formally defining postbiotics as “a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host” (Salminen et al., 2021; DOI: 10.1038/s41575-021-00440-6). The operative word is inanimate. A postbiotic isn’t alive. It doesn’t need to stay alive, because its activity doesn’t depend on viability. It’s typically heat-treated, and its active components — cell-wall fragments, metabolites, short-chain fatty acids, and related compounds — are chemically stable in ways that living cells aren’t.

The stability consequences are substantial and well documented:

• Postbiotics are “more stable than live probiotics, which makes them less sensitive to temperature, light, and pH, making them easy to store and transport” (Hernández-Granados et al., 2024; PMC11321893).
• “Unlike live probiotics, which are sensitive to processing and environmental conditions… postbiotics are inherently more stable as they are composed of inanimate entities. And, postbiotics do not rely on cold chain supply management” (2025; PMC12639491).
• Arrioja-Bretón et al. (2020) found that postbiotic bioactivity was maintained across storage at 15°C, 25°C, and 35°C, “emphasising the suitability of ambient temperatures for preserving postbiotic functions.”

Notice what disappears from the conversation when the ingredient is inanimate. There’s no CFU to count, because CFU is a measure of viable, reproducing organisms. There’s no die-off curve to model. There’s no overfill gamble. There’s no “will it survive the summer warehouse” question. A postbiotic preparation delivers a consistent amount of its active components from manufacture to consumption, because those components aren’t dying on the shelf.

This isn’t a claim that postbiotics are automatically superior to every probiotic. It’s a narrower, defensible point: for a postbiotic, the specific claim we’re fact-checking here doesn’t even apply. You can’t fail an expiration-CFU test if your mechanism of action has nothing to do with live counts. That’s a genuine structural advantage for any owner who has ever looked at a probiotic pouch and wondered what is actually alive inside it on day 89 of a 90-day shelf life.

We go deeper on the mechanism in our analysis of heat-killed postbiotics versus live probiotics.

Even the efficacy premise deserves a reality check

It’s also worth remembering that a perfectly accurate CFU count doesn’t guarantee a clinical benefit. A 2019 randomized, double-blind, placebo-controlled trial in dogs with acute diarrhea found that a probiotic measured at roughly 30 billion CFU at the start of the study performed no better than placebo for time to clinical resolution (Shmalberg et al., 2019; DOI: 10.3389/fvets.2019.00163). A 2021 longitudinal survey in healthy dogs found that two weeks of a commercial probiotic didn’t significantly alter microbiome diversity, and that changes partially reverted to baseline^[4] after supplementation stopped (Manson-Smith et al., 2021; DOI: 10.3389/fvets.2021.664318).

The point isn’t that probiotics never work. It’s that the CFU number is the beginning of the evidence conversation, not the end of it — and when the number itself can’t be independently verified, the conversation hasn’t really started.

What to Ask Any Supplement Company

You don’t need a microbiology lab to pressure-test a CFU claim. You need three questions and a willingness to treat a non-answer as information:

1. “Can you provide a Certificate of Analysis from an independent, ISO 17025-accredited laboratory showing CFU at expiration — not at manufacture?” A confident manufacturer with stability data will send this. A manufacturer that sends a contaminant panel instead has answered a different question.
2. “What is your overfill, and what stability studies support your expiration dating?” Real-time and accelerated stability studies are standard practice for any product making an at-expiration claim.
3. “Can you identify each strain to the strain level, and is there published research on this specific preparation in dogs?” Genus and species aren’t enough. Benefits are strain-specific, and a multi-strain blend is only as credible as the evidence behind each strain.

None of these questions is hostile. They are the minimum a “guaranteed at expiration” claim implies. A brand that can’t answer them isn’t necessarily selling a bad product — but it’s selling an unverified claim, and that’s exactly the category our verdict reflects.

Our Verdict and Why

We rate this claim UNVERIFIABLE, not FALSE. That distinction matters and we don’t use it lightly.

To call the claim FALSE, we would need positive evidence that Boops Pets’ product falls short of its labeled count at expiration — for example, an independent assay showing a large shortfall. We don’t have that. We haven’t plated this product, and neither, as far as we can determine from the public record, has any independent lab whose results are published.

To call it TRUE or VERIFIED, we would need the manufacturer’s own stability data or an independent expiration assay. We don’t have that either.

What we do have is a category with a documented, decades-long label-accuracy problem (27% accuracy in the landmark study; individual-organism concentrations below 2% of label in another), a product format — the soft chew — that’s structurally hostile to live-culture stability, and a complete absence of publicly available, product-specific evidence that the labeled 30 Billion CFU survives to the end of shelf life. In that evidentiary vacuum, the only honest verdict is UNVERIFIABLE. The claim may well be true. It’s simply not supported by anything the public can inspect, and the base rate for the category argues against taking it on faith.

Owners who want to avoid this uncertainty entirely have a structurally different option: a postbiotic-first formulation, where the active ingredient is inanimate and the CFU-survival question doesn’t arise. That isn’t the only reasonable choice, but it’s the choice that makes this particular fact-check moot.

References

1. Weese JS, Martin H. Assessment of commercial probiotic bacterial contents and label accuracy. Canadian Veterinary Journal. 2011;52(1):43-46. PMC3003573.
2. Metras BN, et al. Assessment of commercial companion animal kefir products for label accuracy of microbial composition and quantity. Journal of Animal Science. 2020;98(9):skaa301. DOI: 10.1093/jas/skaa301.
3. Shmalberg J, et al. A Randomized Double Blinded Placebo-Controlled Clinical Trial of a Probiotic or Metronidazole for Acute Canine Diarrhea. Frontiers in Veterinary Science. 2019;6:163. DOI: 10.3389/fvets.2019.00163.
4. Manson-Smith DF, et al. Longitudinal Survey of Fecal Microbiota in Healthy Dogs Administered a Commercial Probiotic. Frontiers in Veterinary Science. 2021;8:664318. DOI: 10.3389/fvets.2021.664318.
5. Salminen S, Collado MC, Endo A, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature Reviews Gastroenterology & Hepatology. 2021;18:649-667. DOI: 10.1038/s41575-021-00440-6.
6. Hernandez-Granados MJ, et al. Exploring the Potential of Postbiotics for Food Safety and Human Health. Foods. 2024. PMC11321893.